Most patients diagnosed with head and neck squamous cell carcinoma (HNSCC) will
present with locally advanced disease, requiring multimodality therapy. While this approach …

The COVID-19 pandemic demands reassessment of head and neck oncology treatment
paradigms. Head and neck cancer (HNC) patients are generally at high-risk for COVID-19 …

Head and neck cancers (HNC) are defined as malignant tumours located in the upper
aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90 …

Oral cancer is a global disease. Despite a well elucidated tumour progression model, these
cancers present late. Attempts at early detection by way of adjunctive diagnostic …

Cancers of the lip and oral cavity are the most common nonmelanoma head and neck
cancer in the world, with approximately 350,000 new cases each year worldwide. 1 For …

Background A novel coronavirus disease (COVID-19) was first reported in December 2019
in China and was soon declared a pandemic by the World Health Organization. Many …

Cancer has gained appreciable attention in the category of noncommunicable health
disorders as the group of proliferative diseases and metabolic syndromes of fatal …

Purpose Although patients aged> 70 years are subject to early oral cavity squamous cell
carcinoma (E-OCSCC), evidence is currently lacking regarding the probable outcomes of …

Surgery should be the primary treatment modality for most resectable oral cavity cancers
and for T4a laryngeal/hypopharyngeal cancers. Primary surgery could also be the preferred …

Simple Summary Cancers of the lip and oral cavity are common cancers worldwide. Up to
46% of oral cancers are preventable if risk factors are avoided and if precancerous lesions …